Suppr超能文献

胃肝样腺癌。临床病理及免疫组化分析。

Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis.

作者信息

Nagai E, Ueyama T, Yao T, Tsuneyoshi M

机构信息

Second Department of Pathology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

出版信息

Cancer. 1993 Sep 15;72(6):1827-35. doi: 10.1002/1097-0142(19930915)72:6<1827::aid-cncr2820720606>3.0.co;2-8.

Abstract

BACKGROUND

The clinicopathologic and immunohistochemical features of the primary gastric hepatoid adenocarcinomas still remain unclear.

METHODS

The authors evaluated 28 hepatoid adenocarcinomas (HC) of the stomach on the basis of characteristic histologic features resembling hepatocellular carcinoma, which were selected from the 7200 cases of primary gastric carcinoma in their files. Additionally, 22 alpha-fetoprotein (AFP)-positive adenocarcinomas without hepatoid features (APC) were also selected.

RESULTS

The HC cases fell into the following two groups: HC with AFP-positive tumor cells (Group 1; 15 cases) and HC without AFP-positive cells (Group 2; 13 cases). Histologically, the glycogen granules and hyaline globules were common features in HC. The incidence of a venous invasion of HC (Groups 1 and 2) was higher than that of APC (Group 3). There were no significant differences among the three groups regarding clinical features, macroscopic features, and the incidence of lymphatic permeation. An immunohistochemical study showed that HC had differentiation into various directions. As for the advanced carcinomas, the 5-year survival rates of patients with HC (Groups 1 and 2) and those with APC (Group 3) were 11.9% (21.4%, 8.3%) and 38.2%, respectively. The prognosis of Group 1 was similar to that of Group 2, but was poorer than that of Group 3.

CONCLUSIONS

The findings suggested that HC, as shown by its characteristic histologic features, had a poor prognosis whether producing AFP or not, and that HC should therefore be distinguished from AFP-positive carcinoma without hepatoid features.

摘要

背景

原发性胃肝样腺癌的临床病理及免疫组化特征仍不明确。

方法

作者从其档案中的7200例原发性胃癌中,基于类似肝细胞癌的特征性组织学特征,评估了28例胃肝样腺癌(HC)。此外,还选取了22例无肝样特征的甲胎蛋白(AFP)阳性腺癌(APC)。

结果

HC病例分为以下两组:有AFP阳性肿瘤细胞的HC(第1组;15例)和无AFP阳性细胞的HC(第2组;13例)。组织学上,糖原颗粒和透明小球是HC的常见特征。HC(第1组和第2组)的静脉侵犯发生率高于APC(第3组)。三组在临床特征、大体特征及淋巴渗透发生率方面无显著差异。免疫组化研究显示HC有不同方向的分化。对于进展期癌,HC(第1组和第2组)患者与APC(第3组)患者的5年生存率分别为11.9%(21.4%,8.3%)和38.2%。第1组的预后与第2组相似,但比第3组差。

结论

研究结果表明,HC具有特征性组织学特征,无论是否产生AFP,其预后均较差,因此HC应与无肝样特征的AFP阳性癌相区分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验